| HLA-DQA1*05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ... Gastroenterology 158 (1), 189-199, 2020 | 397 | 2020 |
| NetworKit: A tool suite for large-scale complex network analysis CL Staudt, A Sazonovs, H Meyerhenke Network Science 4 (4), 508–530, 2016 | 366* | 2016 |
| Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility A Sazonovs, CR Stevens, GR Venkataraman, K Yuan, B Avila, MT Abreu, ... Nature genetics 54 (9), 1275-1283, 2022 | 142* | 2022 |
| Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort K Gettler, R Levantovsky, A Moscati, M Giri, Y Wu, NY Hsu, LS Chuang, ... Gastroenterology 160 (5), 1546-1557, 2021 | 67* | 2021 |
| Rare-variant studies to complement genome-wide association studies A Sazonovs, JC Barrett Annual review of genomics and human genetics 19 (1), 97-112, 2018 | 45 | 2018 |
| Underpowered PANTS: a response to the conclusions of “extended analysis identifies drug-specific association of two distinct HLA class II haplotypes for development of … A Sazonovs, T Ahmad, CA Anderson Gastroenterology 160 (1), 470-471, 2021 | 16 | 2021 |
| P440 Prevalence of NUDT15 polymorphisms and incidence of thiopurine-induced leukopenia in Inflammatory Bowel Disease patients: A systematic review and meta-analysis N Yu, D Sriranganathan, GJ Walker, A Sazonovs, H Wilding, NA Kennedy, ... Journal of Crohn's and Colitis 17 (Supplement_1), i569-i570, 2023 | 7* | 2023 |
| Delay tolerant networking for the socio-economic development in rural South Africa A Galati, A Sazonovs, M Olivares, S Mangold, TR Gross Smart Objects and Technologies for Social Good: Second International …, 2017 | 5 | 2017 |
| It Runs in the Family: What Studying Unaffected Individuals in Simplex and Multiplex Families Tells Us About IBD Development JJ Rudbaek, A Sazonovs, T Jess Gastroenterology, S0016-5085 (24) 05530-6, 2024 | 1 | 2024 |
| HLA-DRB1*01:03 and Severe Ulcerative Colitis MV Vestergaard, AK Nøhr, KH Allin, H Krarup, L Larsen, A Sazonovs, ... JAMA, 2024 | 1 | 2024 |
| It Runs in the Family: What Studying Unaffected Individuals in Simplex and Multiplex Families Tells Us About Inflammatory Bowel Disease Development Rudbaek, Jonas j., A Sazonovs, T Jess GASTROENTEROLOGY 168 (1), 2025 | | 2025 |
| P0817 Large-scale clustering of longitudinal faecal calprotectin and C-reactive protein profiles in Scottish and Danish inflammatory bowel disease N Constantine-Cooke, MV Vestergaard, N Plevris, K Monterrubio-Gómez, ... Journal of Crohn's and Colitis 19 (Supplement_1), i1563-i1565, 2025 | | 2025 |
| OP19 Pre-and Post-diagnostic Metabolomic Biomarker Profiling of Over 700,000 Individuals in Three National Biobanks Enables Prediction of Inflammatory Bowel Disease Onset and … A Sazonovs, K Schut, N Plevris, FA Ottosson, T Jess, JC Barrett, C Lees Journal of Crohn's and Colitis 19 (Supplement_1), i38-i41, 2025 | | 2025 |
| Cystic fibrosis risk variants confer protection against inflammatory bowel disease M Yu, Q Zhang, K Yuan, A Sazonovs, C Stevens, L Fachal, ... medRxiv, 2024.12. 02.24318364, 2024 | | 2024 |
| Large-scale clustering of longitudinal faecal calprotectin and C-reactive protein profiles in inflammatory bowel disease N Constantine-Cooke, MV Vestergaard, N Plevris, K Monterrubio-Gómez, ... medRxiv, 2024.11. 08.24316916, 2024 | | 2024 |
| Genetic risk of inflammatory bowel disease is associated with disease course severity MV Vestergaard, KH Allin, AK Nøhr, JVT Lominchar, HS Christensen, ... medRxiv, 2024.11. 01.24316569, 2024 | | 2024 |
| O24 Exploring the potential utility of NUDT15 pharmacogenetic testing in clinical practice: a ‘focused reverse phenotyping’study within the IBD bioresource C Roberts, A Sazonovs, R Smith, M Bishara, N Chanchlani, S Lin, ... Gut 73 (Suppl 1), A13-A14, 2024 | | 2024 |
| Mo1789 EXPLORING THE POTENTIAL CLINICAL UTILITY OF NUDT15 PHARMACOGENETIC TESTING IN CLINICAL PRACTICE: A'FOCUSED REVERSE PHENOTYPING’COHORT STUDY WITHIN THE UK IBD BIORESOURCE C Roberts, A Sazonovs, R Smith, M Bishara, S Lin, N Chanchlani, ... Gastroenterology 166 (5), S-1112, 2024 | | 2024 |
| Inflammatory bowel disease and risk of more than 1500 comorbidities: A disease-wide pre-and post-diagnostic phenomic association study AC Ebert, R Elmahdi, B Verstockt, M Bøgsted, G Poulsen, A Sazonovs, ... medRxiv, 2024.02. 14.24302206, 2024 | | 2024 |
| OP11 Exploring the potential clinical utility of NUDT15 pharmacogenetic testing in clinical practice: a ‘focused reverse phenotyping’study in the UK IBD Bioresource C Roberts, A Sazonovs, R Smith, M Bishara, S Lin, C Neil, C Bewshea, ... Journal of Crohn's and Colitis 18 (Supplement_1), i19-i20, 2024 | | 2024 |